Only 7% of people with pancreatic cancer survive more than five years. New research from Cardiff University is helping to expand the knowledge of this form of cancer, with the hopes of informing developments of new treatments.
One of the largest and most established tissue banks in the UK has received over £2.4 million in funding to support its valuable contributions to cutting-edge cancer research.
Eight people are diagnosed with acute myeloid leukaemia in the UK each day, accounting for over 2000 deaths each year. But a new potential therapeutic target has been uncovered, which could help improve future treatments.
Over £250,000 of funding is helping researchers at Cardiff University to label and image small biological particles to test their potential use in treating brain disease and cancer.
Cholangiocarcinoma is a rare disease, with only two percent of patients with metastatic disease surviving past five years. But new funding is helping Cardiff University researchers to find out crucial information about this form of cancer.
Over £520,000 has been awarded to help fund world-leading blood stem cell research, which will have a long-lasting impact on bone marrow transplantation and blood transfusion.
